Clinical Trials Browser

Terminated × Lymphoma, Non-Hodgkin × Methylprednisolone Hemisuccinate × Clear all

NCT00482053 2018-05-14

Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Phase 2 Terminated

3 enrolled 13 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00481832 2018-02-14

Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

Phase 2 Terminated

50 enrolled 18 charts

Lymphoma, Non-Hodgkin